Francis CW, Kaplan KL (2006). "Chapter 21. Principles of Antithrombotic Therapy". En Lichtman MA, Beutler E, Kipps TJ; et al. Williams Hematology (7th ed.). ISBN978-0071435918. Arquivado dende o orixinal o 07 de xullo de 2011. Consultado o 05 de outubro de 2011.
Nader, HB; et al. (1999). "Heparan sulfates and heparins: similar compounds performing the same functions in vertebrates and invertebrates?". Braz. J. Med. Biol. Res.32 (5): 529–538. PMID10412563. doi:10.1590/S0100-879X1999000500005.
Gatti, G., Casu, B.; et al. (1979). "Studies on the Conformation of Heparin by lH and 13C NMR Spectroscopy". Macromolecules12 (5): 1001–1007. doi:10.1021/ma60071a044.
Ferro D, Provasoli A; et al. (1990). "Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences". Carbohydr. Res.195 (2): 157–167. PMID2331699. doi:10.1016/0008-6215(90)84164-P.
Agnelli G, Piovella F, Buoncristiani P; et al. (1998). "Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery". N Engl J Med339 (2): 80–5. PMID9654538. doi:10.1056/NEJM199807093390204.
Handoll HHG, Farrar MJ, McBirnie J, Tytherleigh-Strong G, Milne AA, Gillespie WJ (2002). "Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures". Cochrane Database Syst Rev4 (4): CD000305. PMID12519540. doi:10.1002/14651858.CD000305.
Chuang YJ, Swanson R.; et al. (2001). "Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin". J. Biol. Chem.276 (18): 14961–14971. PMID11278930. doi:10.1074/jbc.M011550200.
Petitou M, Herault JP, Bernat A, Driguez PA; et al. (1999). "Synthesis of Thrombin inhibiting Heparin mimetics without side effects". Nature398 (6726): 417–422. PMID10201371. doi:10.1038/18877.
Shaya D, Tocilj A.; et al. (2006). "Crystal structure of heparinase II from Pedobacter heparinus and its complex with a disaccharide product". J. Biol. Chem.281 (22): 15525–15535. PMID16565082. doi:10.1074/jbc.M512055200.
Linhardt RJ, Turnbull JE.; et al. (1990). "Examination of the substrate specificity of heparin and heparan sulfate lyases". Biochemistry29 (10): 2611–2617. PMID2334685. doi:10.1021/bi00462a026.
Desai UR, Wang HM. and Linhardt RJ. (1993). "Specificity studies on the heparin lyases from Flavobacterium heparinum". Biochemistry32 (32): 8140–8145. PMID8347612. doi:10.1021/bi00083a012.
Linker A, Hovingh P. (1972). "Isolation and characterization of oligosaccharides obtained from heparin by the action of heparinase". Biochemistry11 (4): 563–568. PMID5062409. doi:10.1021/bi00754a013.
Shively JE, Conrad HE. (1976). "Formation of anhydrosugars in the chemical depolymerization of heparin". Biochemistry15 (18): 3932–3942. PMID9127. doi:10.1021/bi00663a005.
Warda M, Mao W.; et al. (2003). "Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans.". Comp. Biochem. Physiol. B Biochem. Mol. Biol.134 (1): 189–197. PMID12524047. doi:10.1016/S1096-4959(02)00250-6.
Warda M, Gouda EM.; et al. (2003). "Isolation and characterization of raw heparin from dromedary intestine: evaluation of a new source of pharmaceutical heparin". Comp. Biochem. Physiol. C Toxicol. Pharmacol.136 (4): 357–365. PMID15012907. doi:10.1016/j.cca.2003.10.009.
Linhardt RJ, Ampofo SA.; et al. (1992). "Isolation and characterization of human heparin". Biochemistry31 (49): 12441–12445. PMID1463730. doi:10.1021/bi00164a020.
Chuang W, Christ MD, Peng J, Rabenstein DL. (2000). "An NMR and molecular modeling study of the site-specific binding of histamine by heparin, chemically-modified heparin, and heparin-derived oligosacchrides". Biochemistry.39 (13): 3542–3555. PMID10736153. doi:10.1021/bi9926025.
Marcum JA, McKenney JB.; et al. (1986). "Anticoagulantly active heparin-like molecules from mast cell-deficient mice". Am. J. Physiol.250 (5 Pt 2): H879–888. PMID3706560.
Nader, HB; et al. (1999). "Heparan sulfates and heparins: similar compounds performing the same functions in vertebrates and invertebrates?". Braz. J. Med. Biol. Res.32 (5): 529–538. PMID10412563. doi:10.1590/S0100-879X1999000500005.
Agnelli G, Piovella F, Buoncristiani P; et al. (1998). "Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery". N Engl J Med339 (2): 80–5. PMID9654538. doi:10.1056/NEJM199807093390204.
Handoll HHG, Farrar MJ, McBirnie J, Tytherleigh-Strong G, Milne AA, Gillespie WJ (2002). "Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures". Cochrane Database Syst Rev4 (4): CD000305. PMID12519540. doi:10.1002/14651858.CD000305.
Chuang YJ, Swanson R.; et al. (2001). "Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin". J. Biol. Chem.276 (18): 14961–14971. PMID11278930. doi:10.1074/jbc.M011550200.
Petitou M, Herault JP, Bernat A, Driguez PA; et al. (1999). "Synthesis of Thrombin inhibiting Heparin mimetics without side effects". Nature398 (6726): 417–422. PMID10201371. doi:10.1038/18877.
Shaya D, Tocilj A.; et al. (2006). "Crystal structure of heparinase II from Pedobacter heparinus and its complex with a disaccharide product". J. Biol. Chem.281 (22): 15525–15535. PMID16565082. doi:10.1074/jbc.M512055200.
Linhardt RJ, Turnbull JE.; et al. (1990). "Examination of the substrate specificity of heparin and heparan sulfate lyases". Biochemistry29 (10): 2611–2617. PMID2334685. doi:10.1021/bi00462a026.
Desai UR, Wang HM. and Linhardt RJ. (1993). "Specificity studies on the heparin lyases from Flavobacterium heparinum". Biochemistry32 (32): 8140–8145. PMID8347612. doi:10.1021/bi00083a012.
Linker A, Hovingh P. (1972). "Isolation and characterization of oligosaccharides obtained from heparin by the action of heparinase". Biochemistry11 (4): 563–568. PMID5062409. doi:10.1021/bi00754a013.
Shively JE, Conrad HE. (1976). "Formation of anhydrosugars in the chemical depolymerization of heparin". Biochemistry15 (18): 3932–3942. PMID9127. doi:10.1021/bi00663a005.
Warda M, Mao W.; et al. (2003). "Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans.". Comp. Biochem. Physiol. B Biochem. Mol. Biol.134 (1): 189–197. PMID12524047. doi:10.1016/S1096-4959(02)00250-6.
Ototani N, Kikuchi M, Yosizawa Z. (1981). "Comparative studies on the structures of highly-active and relatively-inactive forms of whale heparin". J Biochem (Tokyo)90 (1): 241–246. PMID7287679.
Warda M, Gouda EM.; et al. (2003). "Isolation and characterization of raw heparin from dromedary intestine: evaluation of a new source of pharmaceutical heparin". Comp. Biochem. Physiol. C Toxicol. Pharmacol.136 (4): 357–365. PMID15012907. doi:10.1016/j.cca.2003.10.009.
Bland CE, Ginsburg H.; et al. (1982). "Mouse heparin proteoglycan. Synthesis by mast cell-fibroblast monolayers during lymphocyte-dependent mast cell proliferation.". J. Biol. Chem.257 (15): 8661–8666. PMID6807978.
Linhardt RJ, Ampofo SA.; et al. (1992). "Isolation and characterization of human heparin". Biochemistry31 (49): 12441–12445. PMID1463730. doi:10.1021/bi00164a020.
Hovingh P, Linker A. (1982). "An unusual heparan sulfate isolated from lobsters (Homarus americanus)". J. Biol. Chem.257 (16): 9840–9844. PMID6213614.
Pejler G, Danielsson A.; et al. (1987). "Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides". J. Biol. Chem.262 (24): 11413–11421. PMID3624220.
Dietrich CP, Paiva JF.; et al. (1999). "Structural features and anticoagulant activities of a novel natural low-molecular-weight heparin from the shrimp Penaeus brasiliensis". Biochim. Biophys. Acta.1428 (2–3): 273–283. PMID10434045.
Medeiros GF, Mendes, A.; et al. (2000). "Distribution of sulfated glycosaminoglycans in the animal kingdom: widespread occurrence of heparin-like compounds in invertebrates". Biochim. Biophys. Acta.1475 (3): 287–294. PMID10913828.
Chuang W, Christ MD, Peng J, Rabenstein DL. (2000). "An NMR and molecular modeling study of the site-specific binding of histamine by heparin, chemically-modified heparin, and heparin-derived oligosacchrides". Biochemistry.39 (13): 3542–3555. PMID10736153. doi:10.1021/bi9926025.
Francis CW, Kaplan KL (2006). "Chapter 21. Principles of Antithrombotic Therapy". En Lichtman MA, Beutler E, Kipps TJ; et al. Williams Hematology (7th ed.). ISBN978-0071435918. Arquivado dende o orixinal o 07 de xullo de 2011. Consultado o 05 de outubro de 2011.
